These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 21640499)
1. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. D'Errico MP; Grimaldi L; Petruzzelli MF; Gianicolo EA; Tramacere F; Monetti A; Placella R; Pili G; Andreassi MG; Sicari R; Picano E; Portaluri M Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e239-46. PubMed ID: 21640499 [TBL] [Abstract][Full Text] [Related]
2. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy. Skyttä T; Tuohinen S; Boman E; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL Radiat Oncol; 2015 Jul; 10():141. PubMed ID: 26159409 [TBL] [Abstract][Full Text] [Related]
3. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Erven K; Florian A; Slagmolen P; Sweldens C; Jurcut R; Wildiers H; Voigt JU; Weltens C Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1172-8. PubMed ID: 23149005 [TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity and cancer therapy: treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease. Wieshammer S; Dreyhaupt J; Müller D; Momm F; Jakob A; Freund U Oncology; 2013; 85(3):137-44. PubMed ID: 23948797 [TBL] [Abstract][Full Text] [Related]
5. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347 [TBL] [Abstract][Full Text] [Related]
6. Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers? Nellessen U; Zingel M; Hecker H; Bahnsen J; Borschke D Chemotherapy; 2010; 56(2):147-52. PubMed ID: 20407242 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869 [TBL] [Abstract][Full Text] [Related]
11. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis of cardiac dose in balloon-based high-dose-rate brachytherapy for left-sided breast cancer. Valakh V; Kim Y; Werts ED; Trombetta MG Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1698-705. PubMed ID: 21601371 [TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-Binding Protein Is an Early Biomarker of Cardiac Function After Radiation Therapy for Breast Cancer. Chalubinska-Fendler J; Graczyk L; Piotrowski G; Wyka K; Nowicka Z; Tomasik B; Fijuth J; Kozono D; Fendler W Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1074-1083. PubMed ID: 30991100 [TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937 [TBL] [Abstract][Full Text] [Related]
16. Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study. De Sanctis V; Alfò M; Vitiello C; Vullo G; Facondo G; Marinelli L; Burocchi S; Gallo G; Valeriani M; Campanella B; Scalabrino G; Russo I; Salerno G; Cardelli P; Osti MF; De Biase L Clin Breast Cancer; 2021 Jun; 21(3):e141-e149. PubMed ID: 33012660 [TBL] [Abstract][Full Text] [Related]
17. Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: A prospective study. Palumbo I; Palumbo B; Fravolini ML; Marcantonini M; Perrucci E; Latini ME; Falcinelli L; Sabalich I; Tranfaglia C; Schillaci G; Mannarino E; Aristei C Breast; 2016 Feb; 25():45-50. PubMed ID: 26547836 [TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients. Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785 [TBL] [Abstract][Full Text] [Related]
19. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice]. Zhang QY; Du JB; Chen YH; Li WZ Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452 [TBL] [Abstract][Full Text] [Related]
20. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors. Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]